News and Trends 20 Jan 2023
DeuterOncology closes financing round to start lung cancer study
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing, to start the phase I clinical study for its lead product DO-2, an improved MET…